Pain Management News and Research

RSS

MEDNAX acquires Holston Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Holston Anesthesia Associates, P.C., a physician group practice based in Kingsport, Tenn. The practice will become part of MEDNAX's American Anesthesiology division and is the third Tennessee-based anesthesiology practice to join this division.

5 Aug 2013

Pharmanest announces positive results from SHACT Phase II study

Karolinska Development: Pharmanest AB announced today positive results from a Phase II-study investigating the efficacy and tolerability of SHACT. The data show that SHACT is effective in reducing pain in connection with intrauterine device insertion. Karolinska Development owns 63% of Pharmanest.

1 Aug 2013

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Pain is defined by the sufferer’s experience. Pain may be severe because it is intense, frequent or sustained, and because it is distressing. The severity of pain is not simply due to what is going on in the joint, but is also affected by how the body processes the pain signals, and the context in which it is experienced.

31 Jul 2013

NeuroMetrix announces business and financial highlights for second quarter

NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.

25 Jul 2013

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

Seattle Cancer Care Alliance doctors were recently honored by a judging panel of their peers for providing outstanding cancer care.

24 Jul 2013

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe.

From BD (Becton, Dickinson and Company) 23 Jul 2013

IT issues pose challenges for health law

News outlets also report on how other changes are affecting small business owners, hospitals and students.

23 Jul 2013

First Edition: July 22, 2013

Today's headlines include reports about the continuing efforts in opposition to the health law as well as a Washington Post investigation into a "flaw" in U.S. health care pricing.

22 Jul 2013

Boston Scientific initiates OPTIMISE trial to study ONS using Precision System for chronic migraine

Boston Scientific Corporation has launched a clinical trial to determine whether occipital nerve stimulation using the Precision System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications.

20 Jul 2013

Cubist initiates bevenopran Phase 3 studies in patients with chronic non-cancer pain and OIC

Cubist Pharmaceuticals, Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain and opioid-induced constipation.

19 Jul 2013

FDA accepts Iroko's submicron indomethacin NDA for treatment of acute pain in adults

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.

16 Jul 2013

UAB researchers study link between sleep and pain among patients with knee osteoarthritis

Researchers at the University of Alabama at Birmingham want to know more about the relationship between sleep and pain.

16 Jul 2013

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.

9 Jul 2013

Wake Forest Baptist to extend innovation in geriatrics education with new GPS program

Wake Forest Baptist Medical Center will maintain its position as a leader in geriatric medicine and medical training with continued grant funding from the Donald W. Reynolds Foundation.

3 Jul 2013

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.

12 Jun 2013

Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker

At the 61st ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced mass spectrometry-based product introductions for life-science and clinical research, for biotech/pharma/CRO customers, as well as for industrial and applied markets. The new mass spectrometry systems and solutions are designed to deliver confident analyses with dramatically enhanced resolution, sensitivity and precision.

10 Jun 2013

Lower-income individuals are more likely to report dissatisfaction with knee replacement surgery

Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees.

22 May 2013

PRIUM creates Centers with Standards database for payer-clients

PRIUM, a medical intervention company that helps reduce the inappropriate use of prescription drugs on workers' compensation claims, wants to highlight good functional restoration clinics and chronic pain management clinics for its payer-clients.

20 May 2013

Joint replacement surgery might be avoidable in the future, suggest scientists

Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage.

20 May 2013

Certain varieties of clay have ability to kill MRSA, says ASU researcher

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

20 May 2013

Pain Management News and Research

MEDNAX acquires Holston Anesthesia Associates

Pharmanest announces positive results from SHACT Phase II study

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

NeuroMetrix announces business and financial highlights for second quarter

SCCA physicians honored as "Top Doctors" for providing outstanding cancer care

BD Saf-T-Intima Safety Integrated IV Catheter System gets European approval for subcutaneous infusion therapy

IT issues pose challenges for health law

First Edition: July 22, 2013

Boston Scientific initiates OPTIMISE trial to study ONS using Precision System for chronic migraine

Cubist initiates bevenopran Phase 3 studies in patients with chronic non-cancer pain and OIC

FDA accepts Iroko's submicron indomethacin NDA for treatment of acute pain in adults

UAB researchers study link between sleep and pain among patients with knee osteoarthritis

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Wake Forest Baptist to extend innovation in geriatrics education with new GPS program

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker

Lower-income individuals are more likely to report dissatisfaction with knee replacement surgery

PRIUM creates Centers with Standards database for payer-clients

Joint replacement surgery might be avoidable in the future, suggest scientists

Certain varieties of clay have ability to kill MRSA, says ASU researcher

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News